Anna Nilsson appointed Professor at KBH
Anna Nilsson has been appointed Professor at KBH and will take up the position on July 1, 2024. Her journey began by chance when she ended up in pediatric oncology during her early years as a pediatric resident. She enjoyed working in the department, which was then called '8an', and over time her interest in research was awakened.
Anna Nilsson, a Professor of clinical pediatric oncology at KBH, from 1 July 2024, has dedicated her career to improving the lives of children with cancer. Her journey began serendipitously when she found herself working as a Pediatric Oncologist early in her ST Pediatrics. She enjoyed her time at the department, which was then called “8:an.” Over the years, her interest shifted towards research.
As a PhD student in an immunology lab, Anna delved into various methods for analyzing vaccine responses. Her clinical research focuses on infections in children with cancer and how to ensure they receive effective vaccine protection.
She collaborates closely with the hospital, making it easier for clinically active doctors and nurses to engage in research.
"I have always been very interested in infections and when we were able to create a doctoral project that dealt with vaccination (which prevents infections) in children with cancer, I really wanted to know more," says Anna Nilsson, Docent at the Department of Women's and Children's Health.
Anna's strong interest in infections led her to create a doctoral project centered around vaccination for children with cancer. By preventing infections, these vaccinations play a crucial role in improving the health outcomes of young patients.
Additionally, Anna contributes to the development of new medicines for children with cancer, aiming to strengthen the trial unit.
Through her clinical work, Anna Nilsson bridges the gap between research and patient care, ultimately benefiting those she serves.